Home | Info | Contact
company
clients
partners
services
ATROPINE INJECTION, BP – AMPOULE
Class Anticholenergic and Antimuscarinic
Description Solution does not contain any antimicrobial agent, or bacteriostat. It is intended as a single dose ampoule. When smaller dosage is needed, remaining solution should be discarded
Contra-indications
Atropine should not be given to patients with closed-angle glaucoma, with myasthenia gravis, with prostatic enlargement. Atropine should not be given to patients who are being treated with a monoamine-oxidase inhibitor, or within ten days of the discontinuation of such treatment
Indications Before the induction of general anaesthesia. In patients with an acute myocardial infarction who have developed a bradycardia or atrioventricular block. For the treatment of intoxication with cholinesterase inhibitors and for intoxication by Amanita muscaria and other mushroom poisonings where the toxic agent is a muscarine-like compound
Dosage Adults: Premedication, IV 0.3-0.6mg immediately before induction of anaesthesia and incremental doses of 0.1mg for the treatment of bradycardia – IM 0.3-0.6mg 30-60 minutes before induction.


SUPPLY SPECIFICAITONS
Product No
Description
Strength
Size
Unit of Sale
431
Single Dose Ampoule
0.6mg/mL
1ml
100


COMPOSITION
Atropine 0.6mg/mL
Sodium Chloride To render solution isotonic
In Water for injection 0ml


Information provided for marketing purpose only.
Consult physician for proper administration.
Copyright © Teejay Pharmaceuticals
Designed by KBSIMM		 Home | About Us | Products | Our Factory | Our Team | Search | Contact Us